Search Results - "Milosevic, Slavoljub"

Major histocompatibility complex class II‐restricted presentation of a cytosolic antigen by autophagy by Nimmerjahn, Falk, Milosevic, Slavoljub, Behrends, Uta, Jaffee, Elizabeth M., Pardoll, Drew M., Bornkamm, Georg W., Mautner, Josef

“…Biochemical and functional studies have demonstrated major histocompatibility complex (MHC) class II‐restricted presentation of peptides derived from cytosolic…”
Get full text

Identification of Major Histocompatibility Complex Class II-Restricted Antigens and Epitopes of the Epstein-Barr Virus by a Novel Bacterial Expression Cloning Approach by MILOSEVIC, Slavoljub, BEHRENDS, Uta, ADHIKARY, Dinesh, MAUTNER, Josef

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Generation of allo-restricted peptide-specific T cells using RNA-pulsed dendritic cells: A three phase experimental procedure by Wilde, Susanne, Geiger, Christiane, Milosevic, Slavoljub, Mosetter, Barbara, Eichenlaub, Sabine, Schendel, Dolores J.

“…Designer T cells expressing transgenic T cell receptors (TCR) with anti-tumor specificity offer new treatment options for cancer patients. We developed a three…”
Get full text

Abstract 1520: Targetable immunogenic tumor specific antigens can be identified in non-coding regions of the genome by Franceschetti, Tiziana, Zhao, Qingchuan, Vincent, Krystel, Perreault, Claude, Milosevic, Slavoljub, Sommermeyer, Daniel

“…Abstract CD8+ cytotoxic T cells are the main mediators of immune responses during cancer immunotherapy. Effective T cell functionality depends on the specific…”
Get full text

In vitro and in vivo priming of T cells using dendritic cells loaded with internal cell localization signals fused cancer testis antigens by Milosevic, Slavoljub

“…Cancer represents a unique cell deregulation disease in patients, therefore it has become clear in recent years that successful treatment will depend on…”
Get full text

MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptors by Leisegang, Matthias, Wilde, Susanne, Spranger, Stefani, Milosevic, Slavoljub, Frankenberger, Bernhard, Uckert, Wolfgang, Schendel, Dolores J

“…The apoptosis inhibitor protein survivin is overexpressed in many tumors, making it a candidate target molecule for various forms of immunotherapy. To explore…”
Get full text

Dendritic cells pulsed with RNA encoding allogeneic MHC and antigen induce T cells with superior antitumor activity and higher TCR functional avidity by Wilde, Susanne, Sommermeyer, Daniel, Frankenberger, Bernhard, Schiemann, Matthias, Milosevic, Slavoljub, Spranger, Stefani, Pohla, Heike, Uckert, Wolfgang, Busch, Dirk H., Schendel, Dolores J.

“…Adoptive transfer of T cells expressing transgenic T-cell receptors (TCRs) with antitumor function is a hopeful new therapy for patients with advanced tumors;…”
Get full text

CD4+ and CD8+ T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT by Steger, Brigitte, Milosevic, Slavoljub, Doessinger, Georg, Reuther, Susanne, Liepert, Anja, Braeu, Marion, Schick, Julia, Vogt, Valentin, Schuster, Friedhelm, Kroell, Tanja, Busch, Dirk H, Borkhardt, Arndt, Kolb, Hans-Jochem, Tischer, Johanna, Buhmann, Raymund, Schmetzer, Helga

“…Abstract T-cells play an important role in the remission-maintenance in AML-patients (pts) after SCT, however the role of LAA- (WT1, PR1, PRAME) or…”
Get full text

Identification of MHC II-Restricted Minor Histocompatibility Antigens After HLA-Identical Stem-Cell Transplantation by MILOSEVIC, Slavoljub, BACHNICK, Barbara, KARIM, Karzan, BORNKAMM, Georg W, WITTER, Klaus, GERBITZ, Armin, MAUTNER, Josef, BEHRENDS, Uta

“…After allogeneic hematopoietic stem-cell transplantation (HSCT), donor-derived T cells may elicit graft-versus-host disease (GVHD) and graft-versus-tumor (GVT)…”
Get full text

Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies by Schuster, Ingrid G., Busch, Dirk H., Eppinger, Elfriede, Kremmer, Elisabeth, Milosevic, Slavoljub, Hennard, Christine, Kuttler, Christina, Ellwart, Joachim W., Frankenberger, Bernhard, Nößner, Elfriede, Salat, Christoph, Bogner, Christian, Borkhardt, Arndt, Kolb, Hans-Jochem, Krackhardt, Angela M.

“…Cell-based immunotherapy in settings of allogeneic stem cell transplantation or donor leukocyte infusion has curative potential, especially in hematologic…”
Get full text

CD4 super(+)and CD8 super(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT by Steger, Brigitte, Milosevic, Slavoljub, Doessinger, Georg, Reuther, Susanne, Liepert, Anja, Braeu, Marion, Schick, Julia, Vogt, Valentin, Schuster, Friedhelm, Kroell, Tanja, Busch, Dirk H, Borkhardt, Arndt, Kolb, Hans-Jochem, Tischer, Johanna, Buhmann, Raymund, Schmetzer, Helga

“…T-cells play an important role in the remission-maintenance in AML-patients (pts) after SCT, however the role of LAA- (WT1, PR1, PRAME) or…”
Get full text

Isolation of antigen-specific CD8+ T lymphocytes in vitro and in vivo by Wehner, Carina, Ellinger, Christian, Raffegerst, Silke, Wilde, Susanne, Mosetter, Barbara, Schendel, Dolores J, Milosevic, Slavoljub

“…Depending on the mechanisms by which cancer develops and the strategies tumors use to escape the immune system, cancer therapies are more or less successful. A…”
Get full text

Induction and isolation of tumor antigen-specific CD4+ T lymphocytes using sorting signal directed MHC class-II expression by Ellinger, Christian, Wehner, Carina, Wilde, Susanne, Schendel, Dolores J, Milosevic, Slavoljub

“…The adoptive transfer of tumor-antigen specific CD8+ T lymphocytes has shown highly promising but somewhat limited benefit in tumor immunotherapy. The poor…”
Get full text

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo by Wehner, Carina, Ellinger, Christian, Raffegerst, Silke, Wilde, Susanne, Mosetter, Barbara, Eckl, Judith, Frankenberger, Bernhard, Weis, Manon, Longinotti, Giulia, Sailer, Nadja, Schendel, Dolores J, Milosevic, Slavoljub

“…In recent years, activation of the patient's immune system to defend against tumors was demonstrated to be a promising alternative strategy to classical cancer…”
Get full text

Epstein‐Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells by Mautner, Josef, Pich, Dagmar, Nimmerjahn, Falk, Milosevic, Slavoljub, Adhikary, Dinesh, Christoph, Heike, Witter, Klaus, Bornkamm, Georg W., Hammerschmidt, Wolfgang, Behrends, Uta

“…The Epstein‐Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein regularly expressed in EBV‐associated malignancies. Immune recognition of…”
Get full text

Direct mapping of MHC class II epitopes by Milosevic, Slavoljub, Behrends, Uta, Christoph, Heike, Mautner, Josef

“…Despite technical improvements, the mapping of MHC class II epitopes within complex antigens by genetic or biochemical methods is still laborious and…”
Get full text

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4 super(+) T helper cells by Mautner, Josef, Pich, Dagmar, Nimmerjahn, Falk, Milosevic, Slavoljub, Adhikary, Dinesh, Christoph, Heike, Witter, Klaus, Bornkamm, Georg W, Hammerschmidt, Wolfgang, Behrends, Uta

“…The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) is the only viral protein regularly expressed in EBV-associated malignancies. Immune recognition of…”
Get full text